Protocol Details

The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers

This study is NOT currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number	92-CC-0141
Sponsoring Institute	National Institutes of Health Clinical Center (CC)
Recruitment Detail	Type: Completed Study; data analyses ongoing Gender: Male & Female Min Age: 18 Max Age: 45
Referral Letter Required	No
Population Exclusion(s)	Children
Special Instructions	Currently Not Provided
Keywords	Hemodynamics; Lung Permeability; Endotoxin Tolerance; Bronchoscopy; Human Recombinant Interleukin-1 Receptor
Recruitment Keyword(s)	Normal Volunteer
Condition(s)	Healthy; Lung Disease; Sepsis; Septic Shock
Investigational Drug(s)	Reference Endotoxin
Investigational Device(s)	None
Intervention(s)	Drug: Reference Endotoxin Drug: Inhaled Nitric Oxide
Supporting Site	NIH Clinical Center

Bacterial infections can progress to a life-threatening illness called septic shock, characterized by low blood pressure and vital organ damage. The syndrome is thought to be caused by parts of the bacteria and by the body's own immune response to the infection. A major bacterial product that interacts with the immune defenses is called endotoxin. This study will examine the body's response to endotoxin in the lungs or bloodstream. When endotoxin is given in small amounts to humans, even though it is not an infection, it triggers a set of responses that are typical of what one would see with a true bacterial infection. This allows us to study the earliest changes in molecules and cells that are involved in some bacterial infections. This type of model is safe and has been used in humans for many years to understand the body's responses during infections.

Normal volunteers 18 to 45 years of age may be eligible for this study. Candidates will have a history and physical examination, blood and urine tests, electrocardiogram (EKG) and chest X-ray. In addition, volunteers 40 to 45 years old will have an exercise stress test to screen for asymptomatic coronary artery disease. Participants will undergo one or more of the following procedures:

Bronchoscopy, Bronchoalveolar Lavage, Bronchial Brushings, and Endobronchial Mucosal Biopsies: These techniques for examining lung function are used routinely in patient care and clinical research. The mouth and nasal and lung airways are numbed with an anesthetic. A bronchoscope (pencil-thin flexible tube) is then passed through the nose into the large airways of the lung. Cells and secretions from the airways are rinsed with salt water (bronchoalveolar lavage) and a flexible brush the size of a pencil tip is passed through the bronchoscope to scrape cells lining the airways. Lastly, pieces of tissue (the size of the ball of a ballpoint pen) lining the airways are removed for examination under the microscope.

Intravenous Endotoxin: A small dose of endotoxin is injected into a vein. Blood samples are drawn at regular intervals for 8 hours after the injection and again after 1, 2, 3, 7 and 14 days to analyze the body's immune response to the bacteria in the blood.

Instilled Endotoxin in the Lungs: A small amount (2 teaspoons) of salt water is squirted through a bronchoscope into a lobe of one lung, and then salt water containing a small dose of endotoxin is squirted into the other lung. Bronchial lavage, brushing, and biopsy (see above) are then done to study the response of the lung to the endotoxin. In addition, air is withdrawn through the bronchoscope to study air components from the lung that was instilled with salt water or endotoxin.

Nitric Oxide Therapy: Endotoxin is instilled in a lung (see above) and then nitric oxide-a colorless, odorless, tasteless gas-mixed with room air in a concentration of 40 parts per million, is given through a cushioned mask placed over the mouth and nose. (Some participants will be given the nitric oxide mixture and others will breathe only room air through the mask to test the effects of the nitric oxide on the lung inflammation.) The mask will be worn continuously for 6 hours and removed before repeat bronchoscopy with lavage, brushing and biopsy.

Some of the above procedures require placement of a catheter (thin plastic tube) in a wrist artery to monitor blood pressure from heartbeat to heartbeat and to collect blood samples. First, the skin is numbed with an anesthetic (lidocaine). A needle is then inserted into the artery, the catheter is slipped over the needle into the vessel, and the needle is removed.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

1. 18 to 45 years of age, either male or female

2. Employees or non-employees are eligible

3. Normal screening examination:

a. history and physical examination, nonsmoker, no concurrent medications including aspirin or nonsteroidal anti-inflammatory drugs, no active medical problems;

b. complete blood count with differential and platelet counts;

c. serum chemistries including creatinine, blood urea nitrogen, glucose, liver enzymes and function tests, electrolytes, prothrombin time, partial thromboplastin time;

d. urinalysis;

e. female subjects must have negative urine pregnancy test within one week of participation;

f. electrocardiogram;

g. chest radiograph.

4. If age is 40 to 45 years, normal submaximal stress test to screen for asymptomatic coronary artery disease.

EXCLUSION CRITERIA:

Pregnancy.

Lactation.

History of recent clinically significant asthma.

Subjects who have an allergy to both sulfa- and penicillin-based drugs will not be eligible for the endotoxin instillation portion of the study.

--Back to Top--

Citations:

Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

Response of man to endotoxin

The cardiovascular response of normal humans to the administration of endotoxin

--Back to Top--

Contacts:

Principal Investigator	Referral Contact	For more information:
Anthony F. Suffredini, M.D. National Institutes of Health Clinical Center (CC) National Institutes of Health Building 10 Room 2C145 10 Center Drive Bethesda, Maryland 20892 (301) 496-9320 asuffredini@cc.nih.gov	Debra Reda, R.N. National Institutes of Health Clinical Center (CC) National Institutes of Health Building 10 Room 2C145 10 Center Drive Bethesda, Maryland 20892 (301) 496-9320 dreda@nih.gov	Patient Recruitment and Public Liaison Office Building 61 10 Cloister Court Bethesda, Maryland 20892-4754 Toll Free: 1-800-411-1222 TTY: 301-594-9774 (local),1-866-411-1010 (toll free) Fax: 301-480-9793 prpl@mail.cc.nih.gov

Clinical Trials Number:

NCT00001303

--Back to Top--

QUESTIONS?

Contact the Patient Recruitment and Public Liaison Office for:

• Details on how to participate in a study
• Details on how to refer a patient to a study

NIH Clinical Studies Information Request

---

Contact the Office of Communications for:

• General information about the NIH Clinical Center

www.cc.nih.gov/contact.shtml

---

Contact the Department Clinical Research Informatics, (DCRI) for:

• Technical questions about Adobe Acrobat and the PDF format
• Technical questions about this web server

webmaster@cc.nih.gov